Evidence map›Paper›PMID 38514264›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2024

[Overexpression of tuftelin and KLF-5 and its clinicopathological features in hepatitis B virus-related hepatocellular carcinoma].

J L Yang, R F Fang, Q Xie, B J Tai, D F Yao, M Yao

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J L YangResearch Center of Clinical Medicine, Affiliated Hospital & Department of Immunology, Medical School, Nantong University, Nantong 226001, China.
R F FangDepartment of Gastrenterology, Affiliated Hospital of Nantong University, Nantong 226001, China.
Q XieDepartment of Infectious Diseases, Haian People's Hospital, Haian 226600, China.
B J TaiDepartment of Infectious Diseases, Affiliated Hospital of Nantong University, Nantong 226001, China.
D F YaoResearch Center of Clinical Medicine, Affiliated Hospital & Department of Immunology, Medical School, Nantong University, Nantong 226001, China Department of Gastrenterology, Affiliated Hospital of Nantong University, Nantong 226001, China.
M YaoResearch Center of Clinical Medicine, Affiliated Hospital & Department of Immunology, Medical School, Nantong University, Nantong 226001, China.
Nantong University · CN

Funding

Nantong Infectious Disease Alliance Fund 202308001National Natural Science Foundation of China 31872738, 81673241
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularDental Enamel ProteinsHepatitis BLiver NeoplasmsGene Expression Regulation, NeoplasticHepatitis B virusHumansKruppel-Like Transcription FactorsPrognosisRNA, MessengerDental Enamel ProteinsKLF5 protein, humanKruppel-Like Transcription FactorsRNA, MessengertuftelinClinicopathological featuresHepatitis B virusHepatocellular carcinomaKLF5PrognosisTUFT1

Identifiers

PMID38514264
PMCPMC12850700
OpenAlexW4394761173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.